HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Hisayoshi Suma Taiko Horii Tadashi Isomura Gerald Buckberg Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Suma, H. Search for Related Content PubMed PubMed Citation Articles by Suma, H. Related Collections Cardiac - other

Eur J Cardiothorac Surg 2006;29:S207-S212
© 2006 Elsevier Science NL

A new concept of ventricular restoration for nonischemic dilated cardiomyopathy

^a The Cardiovascular Institute, Tokyo, Japan
^b Hayama Heart Center, Kanagawa, Japan
^c Option on Bioengineering, California Institute of Technology, Pasadena, CA, USA
^d David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, 62-258 CHS, Los Angeles, CA 90095-1741, USA

Received 17 February 2006; accepted 28 February 2006.

^_* Corresponding author. Tel.: +1 310 206 1027; fax: +1 310 825 5895. (Email: gbuckberg{at}mednet.ucla.edu).

Objective: Left ventricular restoration is used to treat patients with chronic progressive heart failure caused by nonischemic dilated cardiomyopathy. This study addresses the use of site selection to determine either lateral wall or septal exclusion. Methods: Evolution of intraoperative echocardiography to define the site of poorest contraction and use of multiple biopsies to show the nonhomogeneous nature of damage are reviewed. To address the heterogeneity of extent of fibrosis in nonischemic cardiomyopathy, target selection was used to determine the mode of left ventriculoplasty. Either the lateral wall was excluded by partial left ventriculectomy (PLV) or septal anterior ventricular exclusion (SAVE or Pacopexy) was employed if the septum was primarily diseased. Surgical results in 107 high-risk (43% NYHA (New York Heart Association) class III and 57% class IV) patients with idiopathic dilated cardiomyopathy over the past 9 years are reviewed. Results: Overall hospital mortality was 7.1% in 84 elective operations and 60.9% in 23 emergency operations, and fell from 42.8% (6 of 14) to 15.0% (14 of 93), when site selection for the area of left ventricular excision or exclusion was determined by the intraoperative echocardiography test. The SAVE/Pacopexy procedure was performed in 36 patients with 62.2% 5-year survival rate. For the entire cohort of PLV and SAVE/Pacopexy population, overall ejection fraction increased from 20 to 31%, and NYHA class improved from 3.6 to 1.8. The 1-, 5-, and 7-year survival rates were 66.9, 46.0, and 36.2%, respectively. In patients having the operation before inotropic dependent, the survival rate was 78.1, 58.0, and 50.2%, respectively. Conclusions: Left ventriculoplasty is effective for patients with idiopathic dilated cardiomyopathy with heart failure by proper patient selection, appropriate timing of the operation, and choice of the surgical procedure (exclusion site selection).

Key Words: Idiopathic dilated cardiomyopathy • Heart failure ventriculoplasty • Site selection • SAVE • Pacopexy

This article has been cited by other articles:

				H. Suma, H. Tanabe, T. Uejima, S. Suzuki, T. Horii, and T. Isomura Selected ventriculoplasty for idiopathic dilated cardiomyopathy with advanced congestive heart failure: midterm results and risk analysis Eur. J. Cardiothorac. Surg., December 1, 2007; 32(6): 912 - 916. [Abstract] [Full Text] [PDF]

				H. Suma, T. Isomura, T. Horii, and F. Nomura Septal anterior ventricular exclusion procedure for idiopathic dilated cardiomyopathy. Ann. Thorac. Surg., October 1, 2006; 82(4): 1344 - 1348. [Abstract] [Full Text] [PDF]